Avg closing price
Price range

4 Stanley Druckenmiller Recursion Pharmaceuticals Trades

Stanley Druckenmiller acquired 907 Thousand Recursion Pharmaceuticals shares worth $13.6 Million. That's 0.39% of their equity portfolio (33rd largest holding). Stanley Druckenmiller started to build up the position in Recursion Pharmaceuticals in Q3 2021 and continued to invest until Q3 2022. Since then they sold 479 Thousand shares. The stake costed the investor $12.3 Million, netting the investor a gain of 11% so far.

Avg closing price
Price range
Sold 34.6% shares (-479 Thousand shares) Q3 2023
Avg closing price $9.98
Price range $6.59 - $15.86
Increased shares by 406.5% (+1.11 Million shares) Q3 2022
Avg closing price $10.13
Price range $7.83 - $13.60
Increased shares by 5.3% (+13.7 Thousand shares) Q1 2022
Avg closing price $10.63
Price range $6.16 - $18.03
New holding (+260 Thousand shares) Q3 2021
Avg closing price $28.34
Price range $19.03 - $41.33

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!